Search Results - "Klein, H. G."

Refine Results
  1. 1

    Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia by Sandhöfer, N, Metzeler, K H, Rothenberg, M, Herold, T, Tiedt, S, Groiß, V, Carlet, M, Walter, G, Hinrichsen, T, Wachter, O, Grunert, M, Schneider, S, Subklewe, M, Dufour, A, Fröhling, S, Klein, H-G, Hiddemann, W, Jeremias, I, Spiekermann, K

    Published in Leukemia (01-04-2015)
    “…In acute myeloid leukemia (AML), several signaling pathways such as the phosphatidylinositol-3-kinase/AKT and the mammalian target of rapamycin (PI3K/AKT/mTOR)…”
    Get full text
    Journal Article
  2. 2

    Pathogen inactivation technology: cleansing the blood supply by KLEIN, H. G.

    Published in Journal of internal medicine (01-03-2005)
    “…  Klein HG (The Johns Hopkins School of Medicine and Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD, USA). Pathogen…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Allogeneic transfusion risks in the surgical patient by Klein, Harvey G.

    Published in The American journal of surgery (01-12-1995)
    “…The risk of blood transfusion-associated complications has been reduced in the past 10 years through technical advances in testing of blood, viral inactivation…”
    Get full text
    Journal Article Conference Proceeding
  5. 5
  6. 6

    Patient‐specific transfusion‐related acute lung injury by Muniz, M., Sheldon, S., Schuller, R. M., Young, N. S., Klein, H. G., Leitman, S. F., Stroncek, D. F.

    Published in Vox sanguinis (01-01-2008)
    “…Transfusion‐related acute lung injury (TRALI) is one of the leading causes of transfusion‐associated mortality. The inadvertent transfusion of neutrophil…”
    Get full text
    Journal Article
  7. 7

    The Prospects for Red-Cell Substitutes by Klein, Harvey G

    Published in The New England journal of medicine (01-06-2000)
    “…Blood is still the best thing possible to have in our veins, according to Woody Allen, and that is certainly the case when the blood is our own. We are not so…”
    Get full text
    Journal Article
  8. 8

    Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger by Wang, J. K., Klein, H. G.

    Published in Vox sanguinis (01-01-2010)
    “…Therapeutic red blood cell (RBC) transfusion is widely utilized in the management of anaemia. Critically ill intensive care unit (ICU) patients in particular,…”
    Get full text
    Journal Article
  9. 9

    Will Blood Transfusion Ever Be Safe Enough? by Klein, Harvey G

    “…Klein comments on the safety of blood transfusions in the US, noting that, by and large, the protective system against infection that is currently in place has…”
    Get full text
    Journal Article
  10. 10

    Transfusion of recently donated (fresh) red blood cells (RBCs) does not improve survival in comparison with current practice, while safety of the oldest stored units is yet to be established: a meta-analysis by Remy, K. E., Sun, J., Wang, D., Welsh, J., Solomon, S. B., Klein, H. G., Natanson, C., Cortés-Puch, I.

    Published in Vox sanguinis (01-07-2016)
    “…Background and Objectives Preclinical studies generated the hypothesis that older stored red blood cells (RBCs) can increase transfusion risks. To examine the…”
    Get full text
    Journal Article
  11. 11

    Blood substitutes: how close to a solution? by Klein, H G

    Published in Developments in biologicals (2005)
    “…The term "blood substitute" is commonly misused when "red cell substitute (RCS) is meant. The ideal RCS should deliver (i) oxygen; (ii) require no…”
    Get more information
    Journal Article
  12. 12

    Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta‐analysis by Cortés‐Puch, I., Wiley, B. M., Sun, J., Klein, H. G., Welsh, J., Danner, R. L., Eichacker, P. Q., Natanson, C.

    Published in Transfusion medicine (Oxford, England) (01-10-2018)
    “…SUMMARY Aim To evaluate the risks of restrictive red blood cell transfusion strategies (haemoglobin 7–8 g dL−1) in patients with and without known…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Depletion and reaccumulation by BERGSTEN, P, AMITAI, G, KEHRL, J, DHARIWAL, K. R, KLEIN, H. G, LEVINE, M

    Published in The Journal of biological chemistry (15-02-1990)
    “…Ascorbic acid (vitamin C) was found in isolated human mononuclear leukocytes and their purified components in millimolar concentration. Intracellular ascorbic…”
    Get full text
    Journal Article
  17. 17

    Immunologic aspects of blood transfusion by Klein, H G

    Published in Seminars in oncology (01-04-1994)
    “…For 20 years, clinical reports and laboratory observations have suggested that allogeneic blood transfusion effects important changes in the recipient's immune…”
    Get more information
    Journal Article
  18. 18

    A Controlled Comparison of the Efficacy of Hetastarch and Pentastarch in Granulocyte Collections by Centrifugal Leukapheresis by Lee, J.-H., Leitman, S.F., Klein, H.G.

    Published in Blood (15-12-1995)
    “…Compared with hetastarch (HS), the low molecular weight analog pentastarch (PS) has been reported to be equally effective for granulocyte collection by…”
    Get full text
    Journal Article
  19. 19

    Will blood transfusion ever be safe enough? by Klein, H. G.

    Published in Transfusion Medicine (01-04-2001)
    Get full text
    Conference Proceeding Journal Article
  20. 20